Leukemic Cell Proteomic Profiling in Pediatric AML.

被引：0
|
作者：
Nguyen, Nam K. [1 ]
Wu, Huiyun [2 ]
Peng, Junmin [2 ]
Rubnitz, Jeffrey E. [2 ]
Pounds, Stanley [2 ]
Lamba, Jatinder K. [1 ]
机构：
[1] Univ Florida, Coll Pharm, Gainesville, FL USA
[2] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2535
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Allogeneic stem cell transplantation (SCT) for myelodysplastic syndrome and secondary AML.
    Schwerdtfeger, R
    Braeuninger, S
    Prumbaum, M
    Kreissig, C
    Baurmann, H
    BLOOD, 2000, 96 (11) : 364B - 364B
  • [32] Heterogeneous interactions of leukemic and control bone marrow stroma cells with an AML cell line and AML leukemic blasts
    Buttkereit, U.
    Mohamad, S.
    Lindemann, M.
    Goethert, J. R.
    Opalka, B.
    Duerig, J.
    Duehrsen, U.
    ONKOLOGIE, 2010, 33 : 235 - 235
  • [33] Heterogeneous Interactions of Leukemic and Control Bone Marrow Stroma Cells with an AML Cell Line and AML Leukemic Blasts
    Buttkereit, Ulrike
    Mohamad, Sana
    Lindemann, Monika
    Goethert, Joachim R.
    Opalka, Bertram
    Duerig, Jan
    Duehrsen, Ulrich
    BLOOD, 2010, 116 (21) : 460 - 460
  • [34] A Stable and Reproducible Xenotransplant Model for AML.
    Malaise, Muriel
    Doehner, Konstanze
    Reinhardt, Dirk
    Debatin, Klaus-Michael
    Corbacioglu, Selim
    BLOOD, 2009, 114 (22) : 417 - 417
  • [35] Transcriptome Profiling of Pediatric Core Binding Factor AML
    Hsu, Chih-Hao
    Cu Nguyen
    Yan, Chunhua
    Ries, Rhonda E.
    Chen, Qing-Rong
    Hu, Ying
    Ostronoff, Fabiana
    Stirewalt, Derek L.
    Komatsoulis, George
    Levy, Shawn
    Meerzaman, Daoud
    Meshinchi, Soheil
    PLOS ONE, 2015, 10 (09):
  • [36] The effect of chemotherapy on PBPC harvests in AML.
    Lenehan, H
    Burgess, R
    Brereton, ML
    Briggs, M
    Green, LM
    Adams, JA
    Yin, JAL
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 : 55 - 55
  • [37] The protein tyrosine kinase inhibitor SU5614 eradicates leukemic stem cells from patients with AML.
    Arseni, N
    Spiekermann, K
    Buske, C
    Schnittger, S
    Hiddemann, W
    Feuring-Buske, M
    BLOOD, 2002, 100 (11) : 559A - 559A
  • [38] Treg infiltration and the expression of immune checkpoints associated with T cell exhaustion in AML.
    Williams, Patrick
    Basu, Sreyashi
    Garcia-Manero, Guillermo
    Cortes, Jorge E.
    Ravandi, Farhad
    Jabbour, Elias
    Al-Hamal, Zainab
    Konopleva, Marina
    Ning, Jing
    Xiao, Lianchun
    Lopez, Juliana Hidalgo
    Kornblau, Steven
    Andreeff, Michael
    Bueso-Ramos, Carlos E.
    Blando, Jorge M.
    Alatrash, Gheath
    Allison, James Patrick
    Kantarjian, Hagop M.
    Sharma, Padmanee
    Daver, Naval Guastad
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [39] Prognostic significance of progenitor cell doubling time (P-2) in AML.
    Pagliaro, LC
    Drew, MC
    Liu, B
    Freireich, EJ
    BLOOD, 1996, 88 (10) : 3361 - 3361
  • [40] Clinical relevance of CRp in untreated AML.
    Estey, EH
    Garcia-Manero, G
    Giles, FJ
    Cortes, J
    O'Brien, S
    Kantarjian, HM
    BLOOD, 2005, 106 (11) : 161A - 161A
12345